If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.10
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.30 (27.273%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Physiomics secures contract with University of Sheffield

Mon, 19th Feb 2024 10:16

(Sharecast News) - Data science firm Physiomics has been chosen by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment.

Physiomics said on Monday that the contract was valued at £45,000 and will begin in the second half of the year. The group added that the work was in support of one of seven cancer-focussed projects recently announced by the University, all of which will be funded by Yorkshire Cancer Research.

The AIM-listed group added that the work follows on from a pilot project with the University, funded by UK Research and Innovation's Higher Education Innovation Funding scheme, with the project focussed on the development of an insect model of cancer that could be used to screen new drugs prior to pre-clinical testing in more traditional models of cancer and has a particular focus on the prediction of metastasis.

Physiomics' role will be to create mathematical models based on experimental data and to explore the relationship between the effect of drugs in these models, established models, and humans. Physiomics will also provide advice and guidance on the possible commercialisation of the technology.

As of 1010 GMT, Physiomics shares were up 3.7% at 1.40p.

Reporting by Iain Gilbert at Sharecast.com

More News
14 May 2021 10:23

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

Read more
14 May 2021 09:27

Physiomics secures follow-on contract from Merck KgaA

Physiomics secures follow-on contract from Merck KgaA

Read more
14 May 2021 08:27

Physiomics secures additional contract with Merck

(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.

Read more
11 May 2021 17:50

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Read more
11 May 2021 10:46

Physiomics secures contract with Numab Therapeutics

(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.

Read more
10 May 2021 10:21

Physiomics says full-year results to disappoint market forecasts

Physiomics says full-year results to disappoint market forecasts

Read more
10 May 2021 10:19

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

Read more
10 May 2021 08:40

Physiomics FY income likely to fall short of market expectations

(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19 related project delays and an increased focus on longer-term value-generating activities.

Read more
1 Mar 2021 11:29

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

AIM WINNERS & LOSERS: Tlou Energy rises on project funding hopes

Read more
1 Mar 2021 11:22

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

TRADING UPDATES: CentralNic revenue doubles; Augean swing to profit

Read more
15 Feb 2021 16:04

Physiomics and ValiRx enter new collaboration deal

(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.

Read more
15 Feb 2021 11:05

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

Read more
17 Dec 2020 15:52

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

UK TRADING UPDATE SUMMARY: Focusrite Revenue Grows On Strong Demand

Read more
17 Dec 2020 13:59

Physiomics gets initial 2021 commitment from client Merck

(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.

Read more
14 Dec 2020 19:35

UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares

UK TRADING UPDATE SUMMARY: Airtel Investor To Sell 60 Million Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.